PharmacoEconomics and Outcomes News

The National Vaccine Advisory Committee (NVAC) has released a report on strengthening the supply of routinely recommended vaccines in the US.
pp. 2-2(1)

Guidelines for the management of cutaneous T-cell lymphoma have been released in the UK.
pp. 2-2(1)

Access to antiretrovirals in developing countries attainable
pp. 2-2(1)

Cost implications of guideline differences in hypertension
pp. 3-3(1)

US physicians' role in improving coverage, cost and quality of care
pp. 3-3(1)

Decline in HRT use confirms physicians' rapid response
pp. 4-4(1)

Patients with migraine have only a "slight increased use of antidepressants" compared with the population without migraine
pp. 4-4(1)

HFA-beclometasone more effective, less costly than CFC version
pp. 4-4(1)

Insulin dosing device cuts costs, proves popular with the elderly
pp. 4-4(1)

Preoperative radiotherapy worth it in rectal cancer
pp. 5-5(1)

Antibacterials overused for RTIs in Italy
pp. 5-5(1)

Levosalbutamol helps paediatric ED patients breathe easy
pp. 5-5(1)

A high rate of -blocker use can be achieved in patients seen at a specialised outpatient heart failure (HF) clinic
pp. 6-6(1)

Comorbid disease linked to asthma severity, corticosteroids underused
pp. 6-6(1)

ADHD cost burden extends to family members
pp. 6-6(1)

Psychotropic use less likely among ethnic minorities
pp. 6-6(1)

Screening for proteinuria warranted in the US?
pp. 7-7(1)

Palifermin reduces resource use in stomatitis
pp. 7-7(1)

Antidepressant use linked to shorter work absences in depression
pp. 7-7(1)

Neuropsychotherapeutics often used among elderly residents in Sweden
pp. 8-8(1)

Headache care in the ED not ideal
pp. 8-8(1)

Benefit of newer antipsychotics not clear cut
pp. 8-8(1)

Atypical antipsychotics associated with less medication switching
pp. 9-9(1)

WTP driven by socioeconomics not clinical status in OA
pp. 9-9(1)

Potential for big savings with obesity prevention programme
pp. 9-9(1)

Research carried out on the effect of the `Wise Use of Antibiotics' campaign in New Zealand by research agency Colmar Brunton has found that, compared with 3 years ago, people are less likely to expect an antibacterial to treat common colds
pp. 9-9(1)

Torasemide outshines furosemide in QOL stakes
pp. 10-10(1)

Epoetin alfa dosing schedule affects QOL in anaemic HIV patients
pp. 10-10(1)

Rivastigmine leads to clinically relevant QOL improvement
pp. 10-10(1)

Generic AIDS drug deal settled by GSK and Boehringer in S Africa
pp. 11-11(1)

The price of generic simvastatin [Vidastat] has been slashed in the Philippines by pharma company Therapharma (United Laboratories)
pp. 11-11(1)

Patients likely to pay more under German health reform
pp. 11-11(1)

A value pricing model in conjunction with a unique dosing combination are among plans for the launch of Eli Lilly's bipolar depression therapy Symbyax
pp. 11-11(1)

NZ Health Minister proposes move to veto DTC drug advertising
pp. 11-11(1)

An agreement signed between WHO and Novartis will see half a million of the world's poorest tuberculosis (TB) patients receive life-saving drugs free of charge.
pp. 11-11(1)